Kojic Acid Cream: What the Trials Show, What Strength Is Safe, and How to Use It

Kojic Acid Cream: What the Trials Show, What Strength Is Safe, and How to Use It

Many kojic acid studies tested a cream, not a serum or soap. Here is what those trials found, why the formula matters, and how to pair a kojic acid cream with retinol for dark spots

If you search for kojic acid, you will find serums, soaps, peels and creams. The cream is the format with the most clinical history. Many of the human trials of kojic acid for dark patches tested it in a cream base, often alongside another brightener, and that tells you a lot about how to use one well.

This guide covers what those trials found, why a cream base suits some skin types better than a serum, what strength is sensible for daily use, and how a kojic acid cream works with retinol.

How kojic acid works

Kojic acid comes from the same Aspergillus fermentation used to make sake and soy sauce. It slows pigment production by binding the copper at the core of tyrosinase, the enzyme that turns the amino acid tyrosine into melanin [1]. Without that copper, the enzyme cannot do its job, and new pigment forms more slowly.

That mechanism sets expectations from day one. Kojic acid prevents new melanin, but the pigment already sitting in your dark spot has to be shed by normal skin turnover. Your skin needs about 12 weeks of nightly kojic acid cream to show a visible change, which is longer than most people wait before giving up.

What the cream trials actually found

The research is small but consistent, and it points in one direction: kojic acid helps, modestly, and works best in combination.

Your skin needs about 12 weeks of nightly kojic acid cream to show a visible change, which is longer than most people wait before giving up.

  • Kojic acid with and without partners. In a randomized study of 80 people with melasma, a nightly 1% kojic acid cream was compared with the same cream combined with 2% hydroquinone, with a steroid, or with both, over 12 weeks. Kojic acid plus hydroquinone performed best, kojic acid alone did reasonably well, and the steroid combination performed worst [2].
  • Against hydroquinone. A 0.75% kojic acid cream with 2.5% vitamin C was compared with 4% hydroquinone cream in 60 people over 12 weeks. Hydroquinone worked faster and better overall [3]. Our guide to hydroquinone for dark spots explains why it remains the benchmark, and why many people still look for alternatives.
  • Against cysteamine. In 72 women using either 2% kojic acid cream or 5% cysteamine cream nightly for 16 weeks, both groups improved by similar small amounts, about 10% for kojic acid and 12% for cysteamine on a standard severity score, with no adverse effects reported in either group [4]. The study was funded by the maker of the cysteamine cream.
  • With alpha-arbutin. A cosmetic cream containing 5% alpha-arbutin and 2% kojic acid was compared with a prescription triple-combination cream in 30 people with melasma, one product on each side of the face, for 12 weeks. Pigment measurements improved similarly on both sides, the kojic acid side had less redness and stinging, and pigment returned less severely after treatment stopped [5].

The honest summary is that kojic acid cream is a gentle, slow, supporting brightener. It earns its place in a combination routine more than as a single answer.

Why a cream base can help

Pure kojic acid is unstable. It reacts with light, heat and air, turning yellow-brown and losing activity as it oxidizes [1]. A well-made cream can protect it better than a thin water-based serum, especially in opaque, airless packaging.

Many creams use kojic dipalmitate, an oil-soluble ester marketed as the more stable form. The lab evidence is more nuanced. When researchers exposed both molecules to oxidizing conditions in solution, the dipalmitate ester actually degraded faster than kojic acid itself. The authors recommended adding antioxidants and placing the ester in the oil phase of an emulsion to protect it [6]. That is an argument for a properly formulated cream, not a reason to assume any dipalmitate product is stable.

A cream also suits dry and mature skin, and it is easier to spread over larger areas such as the backs of the hands, the chest and the forearms. If you prefer something lighter for oily skin, our guide to kojic acid serum covers that format.

Your skin may improve by only about 10% after 16 weeks of kojic acid cream used alone, which is far less than most marketing photos suggest.

What strength is sensible

Many kojic acid creams advertise 2% to 4%. The safety evidence suggests more caution. Kojic acid can cause allergic contact dermatitis. In a year of patch testing in Japan, five of the eight patients who had used kojic acid skin care products reacted to the ingredient, and their facial rashes appeared one to twelve months after they started using it [7]. The Cosmetic Ingredient Review expert panel concluded that kojic acid is safe in cosmetics at concentrations up to 1%, the level below which neither sensitization nor unwanted skin lightening was expected [8].

A practical approach:

  • Choose around 1% for daily facial use, and patch test on your inner arm for several days first.
  • Treat 2% and above as short-term or spot use, and stop at the first sign of itching or rash, even after weeks of uneventful use.
  • Check the jar. A cream that has turned noticeably brown has lost potency.
  • Skip fragrance. It adds allergy risk to an ingredient that already carries some.

How to use a kojic acid cream

Apply a thin layer once daily, usually at night, to clean, dry skin over the areas you want to treat. Most trials used nightly application. In the morning, broad-spectrum sunscreen is essential, because daily UV and visible light keep restarting the pigment cycle that kojic acid is trying to slow. Our guide to sunscreen for hyperpigmentation explains which filters protect best against both.

Expect gradual change and judge results at 12 weeks, not 12 days. Your skin may improve by only about 10% after 16 weeks of kojic acid cream used alone, which is far less than most marketing photos suggest.

Where retinol does the work kojic acid cannot

Kojic acid slows new pigment. Retinoids speed the turnover that carries existing pigment up and out of the skin. In a 40-week vehicle-controlled trial in women with melasma, 68% of those using 0.1% tretinoin improved, compared with 5% on the plain cream, and pigment in the outer skin fell by 36%. The trade-off was irritation: 88% had redness and peeling [9]. Our guide to retinol for dark spots explains how gentler over-the-counter retinol uses the same pathway.

That irritation matters more than it seems, because inflamed skin can produce more pigment, not less.

A routine for spots that respects your skin

Nanoretinol was designed to remove that trade-off. It delivers 0.2% stabilized retinol inside biomimetic lipid nanoparticles that the skin recognizes as its own, so the retinol reaches skin cells without breaking down the barrier the way conventional formulations can. In North Biomedical’s study summary, Nanoretinol was 232% more effective in collagen recovery than conventional retinol, with side effects that were minimal and milder than those of conventional retinol [10].

A simple split works well: kojic acid cream on alternate nights, Nanoretinol on the nights in between, and sunscreen every morning. If your skin stays calm after a few weeks, you can keep that rhythm for the long run. Kojic acid slows new pigment, retinol clears what is already there, and sunscreen stops the cycle from starting again.

References

  1. Saeedi M, Eslamifar M, Khezri K. “Kojic acid applications in cosmetic and pharmaceutical preparations.” Biomedicine & Pharmacotherapy. 2019;110:582-593. doi:10.1016/j.biopha.2018.12.006
  2. Deo KS, Dash KN, Sharma YK, Virmani NC, Oberai C. “Kojic Acid vis-a-vis its Combinations with Hydroquinone and Betamethasone Valerate in Melasma: A Randomized, Single Blind, Comparative Study of Efficacy and Safety.” Indian Journal of Dermatology. 2013;58(4):281-285. doi:10.4103/0019-5154.113940
  3. Monteiro RC, Kishore BN, Bhat RM, Sukumar D, Martis J, Ganesh HK. “A Comparative Study of the Efficacy of 4% Hydroquinone vs 0.75% Kojic Acid Cream in the Treatment of Facial Melasma.” Indian Journal of Dermatology. 2013;58(2):157. doi:10.4103/0019-5154.108070
  4. Patil R, Dhoot D, Balasubramanian A, Patil S, Barkate H. “Comparison of the Effectiveness and Safety of 5% Cysteamine and 2% Kojic Acid Creams in the Treatment of Melasma in Indian Adult Females.” Cureus. 2025;17(3):e81330. doi:10.7759/cureus.81330
  5. Tantanasrigul P, Sripha A, Chongmelaxme B. “The Efficacy of Topical Cosmetic Containing Alpha-Arbutin 5% and Kojic Acid 2% Compared With Triple Combination Cream for the Treatment of Melasma: A Split-Face, Evaluator-Blinded Randomized Pilot Study.” Journal of Cosmetic Dermatology. 2025;24(1):e16562. doi:10.1111/jocd.16562
  6. Tazesh S, Tamizi E, Siahi Shadbad M, Mostaghimi N, Monajjemzadeh F. “Comparative Stability of Two Anti-hyperpigmentation Agents: Kojic Acid as a Natural Metabolite and Its Di-Palmitate Ester, Under Oxidative Stress; Application to Pharmaceutical Formulation Design.” Advanced Pharmaceutical Bulletin. 2022;12(2):329-335. doi:10.34172/apb.2022.031
  7. Nakagawa M, Kawai K, Kawai K. “Contact allergy to kojic acid in skin care products.” Contact Dermatitis. 1995;32(1):9-13. doi:10.1111/j.1600-0536.1995.tb00832.x
  8. Burnett CL, Bergfeld WF, Belsito DV, et al. “Final report of the safety assessment of kojic acid as used in cosmetics.” International Journal of Toxicology. 2010;29(6 Suppl):244S-273S. doi:10.1177/1091581810385956
  9. Griffiths CE, Finkel LJ, Ditre CM, Hamilton TA, Ellis CN, Voorhees JJ. “Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial.” British Journal of Dermatology. 1993;129(4):415-421. doi:10.1111/j.1365-2133.1993.tb03169.x
  10. North Biomedical LLC. “Nanoretinol vs. Conventional Retinol: Efficacy in Collagen and Elastin Recovery.” Clinical Study Summary, 2024. Study summary
Connor Law
Written by
Connor Law
COO, North Biomedical LLC

Connor Law is the COO of North Biomedical LLC, a pioneering biomedical company specializing in advanced delivery systems for proven skincare ingredients.